addressalign-toparrow-leftarrow-rightbackbellblockcalendarcameraccwcheckchevron-downchevron-leftchevron-rightchevron-small-downchevron-small-leftchevron-small-rightchevron-small-upchevron-upcircle-with-checkcircle-with-crosscircle-with-pluscontroller-playcrossdots-three-verticaleditemptyheartexporteye-with-lineeyefacebookfolderfullheartglobegmailgooglegroupshelp-with-circleimageimagesinstagramFill 1linklocation-pinm-swarmSearchmailmessagesminusmoremuplabelShape 3 + Rectangle 1ShapeoutlookpersonJoin Group on CardStartprice-ribbonprintShapeShapeShapeShapeImported LayersImported LayersImported Layersshieldstartickettrashtriangle-downtriangle-uptwitteruserwarningyahoo

Radspinner & Bilsel from Flugen to talk about business of the influenza virus

With a flu shot available on every corner, what are the unmet needs in flu vaccines? Paul Radspinner, CEO of FluGen, and Pamuk Bilsel, CSO of FluGen,  will tackle this question as well as others about the scientific challenges that lead to business opportunities for their company. Radspinner is an experienced pharma deal maker, former licensing manager at WARF. Bilsel has played a key role in vaccine development for companies such as Pharmexa-Epimmune, Pentamer Pharmaceuticals, and Aviron.



Join or login to comment.

  • David S.

    Excellent discussion on the influenza vaccine market and vaccine development. Very engaging and informative.

    October 15, 2013

Our Sponsors

People in this
Meetup are also in:

Sign up

Meetup members, Log in

By clicking "Sign up" or "Sign up using Facebook", you confirm that you accept our Terms of Service & Privacy Policy